← FDA Drug Approvals (Drugs@FDA)
MONTELUKAST SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BRECKENRIDGE · Approved 2020-10-30
Drug application
- FDA Application #
ANDA205319- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MONTELUKAST SODIUM
- Generic name
- Montelukast Sodium
- Active ingredients
- MONTELUKAST SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- BRECKENRIDGE
- First approval
- 2020-10-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown